Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials - Concepedia

Concepedia

Publication | Open Access

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials

DOI Full Paper Access

69

Citations

17

References

2018

Year

Soumi Gupta, Kelly Lau, Cary O. Harding, Gillian Shepherd, Ryan Boyer, John Atkinson, Vijaya Knight, Joy Olbertz, Kevin Larimore, Zhonghu Gu,

Abstract

Despite a universal ADA response post-pegvaliase administration, adult patients with PKU achieved substantial and sustained blood Phe reductions with a manageable safety profile. FUND: BioMarin Pharmaceutical Inc.

References

	Year	Citations

Page 1